Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China
· Delayed Price · Currency is CNY 60.50
-1.31 (-2.12%)
At close: Dec 5, 2025
SHE:002294 Revenue
Shenzhen Salubris Pharmaceuticals had revenue of 1.11B CNY in the quarter ending September 30, 2025, with 15.85% growth. This brings the company's revenue in the last twelve months to 4.25B, up 8.76% year-over-year. In the year 2024, Shenzhen Salubris Pharmaceuticals had annual revenue of 4.01B with 19.22% growth.
Revenue (ttm)
4.25B
Revenue Growth
+8.76%
P/S Ratio
15.86
Revenue / Employee
1.18M
Employees
3,596
Market Cap
67.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.01B | 646.89M | 19.22% |
| Dec 31, 2023 | 3.37B | -116.67M | -3.35% |
| Jan 1, 2023 | 3.48B | 423.62M | 13.85% |
| Jan 1, 2022 | 3.06B | 319.83M | 11.68% |
| Dec 31, 2020 | 2.74B | -1.73B | -38.74% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |